sirolimus-eluting stents

シロリムス溶出ステント

WordNet

1. a slender tube inserted inside a tubular body part (as a blood vessel) to provide support during and after surgical anastomosis

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. ベアメタル冠動脈ステントと比較した薬剤溶出性冠動脈ステント drug eluting compared to bare metal intracoronary stents
• 2. 薬剤溶出性冠動脈ステントの比較 comparison of drug eluting intracoronary stents
• 3. 薬剤溶出性冠動脈ステント：一般原則 drug eluting intracoronary stents general principles
• 4. 特定の冠動脈病変に対する冠動脈ステントの使用 use of intracoronary stents for specific coronary lesions
• 5. 冠動脈ステント留置術後の抗血小板療法 antiplatelet therapy after coronary artery stenting

English Journal

• Nine-year follow-up of progressive peri-stent contrast staining after Cypher sirolimus-eluting stent implantation: a case report.

• Hyogo M1, Sawada T2, Shiraishi J2, Kohno Y2.
• Cardiovascular intervention and therapeutics.Cardiovasc Interv Ther.2016 Aug 24. [Epub ahead of print]
• A 62-year-old male underwent three percutaneous coronary interventions involving four bare metal stents and six Cypher sirolimus-eluting stents within 1 month. At the latest coronary angiographic examination, all of the Cypher stents, but none of the bare metal stents, exhibited peri-stent contrast
• PMID 27558119

• Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials.

• Xhepa E1, Tada T1, Kufner S1, Ndrepepa G1, Byrne RA1, Kreutzer J1, Ibrahim T2, Tiroch K3, Valgimigli M4, Tölg R5, Cassese S1, Fusaro M1, Schunkert H1,6, Laugwitz KL2,6, Mehilli J6,7, Kastrati A1,6.
• Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.Catheter Cardiovasc Interv.2016 Aug 12. doi: 10.1002/ccd.26645. [Epub ahead of print]
• OBJECTIVES: To evaluate the long-term prognostic value of risk scores in the setting of drug-eluting stent (DES) implantation for uLMCA.BACKGROUND: Data on the prognostic value of novel risk scores developed to select the most appropriate revascularization strategy in patients undergoing DES implant
• PMID 27515100

• Direct implantation of rapamycin-eluting stents with bioresorbable drug carrier technology utilising the Svelte coronary stent-on-a-wire: the DIRECT II study.

• Verheye S1, Khattab AA, Carrie D, Stella P, Slagboom T, Bartunek J, Onuma Y, Serruys PW.
• EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.EuroIntervention.2016 Aug 5;12(5):e615-22. doi: 10.4244/EIJV12I5A101.
• AIMS: Our aim was to demonstrate the safety and efficacy of the Svelte sirolimus-eluting coronary stent-on-a-wire Integrated Delivery System (IDS) with bioresorbable drug coating compared to the Resolute Integrity zotarolimus-eluting stent with durable polymer in patients with de novo coronary arter
• PMID 27497361

Japanese Journal

• Five-year clinical outcomes after implantation of sirolimus-eluting stents in patients with and without diabetes mellitus

• Sato Tetsuya,Ono Tamaki,Morimoto Yoshimasa [他]
• Cardiovascular intervention and therapeutics 27(3), 189-195, 2012-09
• NAID 40019426594

• Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation : 5-year outcome of the j-Cypher registry

• Kimura Takeshi,Morimoto Takeshi,Nakagawa Yoshihisa [他]
• Cardiovascular intervention and therapeutics 27(3), 181-188, 2012-09
• NAID 40019426588

---

★リンクテーブル★

関連記事	「stenting」

「stenting」

　　[★]

• n.

• ステント留置、ステント挿入、ステント術

関

stent implantation、stent placement、stented